These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4985285)

  • 41. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 42. [Resistance of Mycobacterium tuberculosis isolated from guinea pigs infected with a mixture of strains sensitive and resistant to tubazid].
    Belogurova VP
    Probl Tuberk; 1967; 45(5):81-5. PubMed ID: 4979497
    [No Abstract]   [Full Text] [Related]  

  • 43. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

  • 44. Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Otto-Knapp R; Vesenbeckh S; Schönfeld N; Bettermann G; Roth A; Bauer T; Rüssmann H; Mauch H
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1275-6. PubMed ID: 27510258
    [No Abstract]   [Full Text] [Related]  

  • 45. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.
    Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S
    Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late emergence of isoniazid-susceptible organisms in guinea pigs challenged with a homogeneous isoniazid-resistant strain on Mycobacterium tuberculosis.
    Noufflard-Guy-Loe H; Berteaux S
    Am Rev Respir Dis; 1966 Oct; 94(4):540-52. PubMed ID: 4958873
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates].
    Wu X; Zhang J; Hu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):727-9. PubMed ID: 11480074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoniazid treatment for tuberculosis.
    Stadler ET; Steiner M
    N Engl J Med; 1971 Apr; 284(13):730-1. PubMed ID: 4993672
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 51. [Epidemiological importance of resistant strains of Mycobacterium tuberculosis (experimental study)].
    Chertkova EI; Udilova NN; Chernigovskaia NN
    Probl Tuberk; 1966; 44(7):67-71. PubMed ID: 4969292
    [No Abstract]   [Full Text] [Related]  

  • 52. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Studies on mutation of isoniazid resistant genes in M. tuberculosis].
    Yao MH; Lou YH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):195-6. PubMed ID: 12536677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Oxygen consumption in Mycobacterium tuberculosis strains and its relation to isoniazid resistance and virulence].
    Hergt R
    Z Allg Mikrobiol; 1973; 13(4):315-22. PubMed ID: 4203834
    [No Abstract]   [Full Text] [Related]  

  • 56. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
    Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S
    Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The bacteriological principles of tuberculosis treatments].
    Grosset J
    Rev Prat; 1979 Jun; 29(33):2645-50. PubMed ID: 113863
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of acridine compounds on the development of drug resistance to antitubercular agents of Mycobacterium of avian type].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1969 Apr; 14(4):355-8. PubMed ID: 4977641
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the problem of the inactivation of antibacterial drugs and drug resistance of disease agents].
    Rudoĭ NM; Lubenson AS
    Biull Eksp Biol Med; 1969 Feb; 67(2):43-5. PubMed ID: 4980639
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
    Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.